CME Group Inc (CME) FinancialsCMECME Group Inc

Evaluating the bottom line, CME Group Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 80.90%, while the net margin is 33.22%. These profitability ratios, combined with a Return on Equity (ROE) of 15.72%, provide a clear picture of how effectively CME converts its operational activities into shareholder value.

In the context of the broader market, CME competes directly with industry leaders such as HOOD and BNY. With a market capitalization of $99.69B, it holds a leading position in the sector. When comparing efficiency, CME's gross margin of N/A stands against HOOD's 95.26% and BNY's N/A. Such benchmarking helps identify whether CME Group Inc. is trading at a premium or discount relative to its financial performance.

CME has shown consistent revenue growth, with Q2 2026 revenue at $3.136 billion and net income at $1.041 billion, reflecting a net margin of 33.22%.